Loma Linda, California 92354


Purpose:

The purpose of this study is to understand the role of specific B cells in activating or repressing an anti-allograft immune response after kidney transplantation. In this study, blood will be collected from kidney transplant patients during different timepoints, prior to and after their transplant. Knowledge gained from study findings will be used to develop therapeutic strategies to prevent antibody-mediated rejection, which is a major cause of long-term graft loss in kidney transplant patients.


Study summary:

The purpose of this study is to understand the role of specific B cells in activating or repressing an anti-allograft immune responses after kidney transplantation. This study aims to address two major challenges in kidney transplantation: 1. to guide physicians when immunosuppressive drugs are weaned, and 2. to identify patients who are at risk or in the process of developing antibody-mediated rejection. In this study, blood will be collected from kidney transplant patients during different timepoints, prior to and after their transplant. Knowledge gained from study findings will be used to develop therapeutic strategies to prevent antibody-mediated rejection, which is a major cause of long-term graft loss in kidney transplant patients.


Criteria:

Inclusion Criteria: - Ability to understand and willingness to sign the written informed consent form (ICF). For pediatric patients, a parent or legal guardian must sign ICF - Either a Kidney or Liver transplant patient: 1) on the waitlist or 2) transplanted - Healthy volunteer samples collected to use as the control group for statistical validity Exclusion Criteria: - Inability to make all of the required long-term post-transplant visits. - Females who are pregnant or nursing a child - Liver patients with hepatitis C virus


NCT ID:

NCT02294032


Primary Contact:

Principal Investigator
Michael de Vera, MD, FACS
Loma Linda University Medical Center

Diane Scavone
Phone: 909-558-3636
Email: DScavone@llu.edu


Backup Contact:

N/A


Location Contact:

Loma Linda, California 92354
United States

Michael de Vera, MD
Phone: 909-558-3636
Email: mdevera@llu.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.